Moleculin Biotech, Inc.
Company Stats
- Market Cap
- $9.7M
- as of Sep 30, 2026
- Shares Outstanding
- 19.5M
- Free Float
- 82.8%
Income Statement
- Revenue
- $0
- Operating Income
- -$25.1M
- Net Income
- -$33.6M
- EBITDA
- -$25.0M
Cash Flow
- Free Cash Flow
- -$22.7M
- FCF Yield
- -233.3%
- Owner FCF Yield
- -250.3%
Balance Sheet
- Cash & Equivalents
- $8.9M
Returns & Capital
- SBC, 3Y Avg
- $1.8M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | -$22.7M | — |
| FY2024 | $0 | -$23.9M | — |
| FY2023 | $0 | -$23.7M | — |
| FY2022 | $0 | -$27.7M | — |
| FY2021 | $0 | -$19.0M | — |
Annual filing data through FY ended December 31, 2025; shares and float as of November 3, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Insiders Buy Into Boston Scientific Restructuring